BR100 Increased By (0.01%)
BR30 Increased By (0.53%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.38 Increased By ▲ 0.06 (0.95%)
BECO 4.35 Increased By ▲ 0.08 (1.87%)
BML 62.55 Increased By ▲ 0.10 (0.16%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.73 Increased By ▲ 0.14 (1.21%)
CSIL 5.91 Increased By ▲ 0.19 (3.32%)
FCCL 61.71 Increased By ▲ 0.17 (0.28%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.69 Increased By ▲ 0.01 (0.04%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.32 Decreased By ▼ -1.96 (-1.12%)
NCPL 51.83 Decreased By ▼ -0.94 (-1.78%)
NPL 54.03 Decreased By ▼ -0.09 (-0.17%)
OGDC 315.87 Increased By ▲ 2.48 (0.79%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.58 Decreased By ▼ -0.22 (-0.61%)
PIBTL 13.66 Increased By ▲ 0.19 (1.41%)
PPL 226.07 Increased By ▲ 4.26 (1.92%)
PRL 80.28 Increased By ▲ 1.20 (1.52%)
PTC 46.64 Decreased By ▼ -0.21 (-0.45%)
SSGC 23.82 Decreased By ▼ -0.05 (-0.21%)
TBL 9.24 Decreased By ▼ -0.07 (-0.75%)
TELE 7.55 Increased By ▲ 0.16 (2.17%)
TPL 24.54 Decreased By ▼ -0.57 (-2.27%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 25.98 Decreased By ▼ -0.27 (-1.03%)
TRG 53.33 Decreased By ▼ -0.11 (-0.21%)
اردو
Android App
Print Edition Dollar to PKR
Daily Petrol Prices IMF-World Bank meetings Intl Oil Prices Iran-US war Gold Rates Podcasts PSX Notices
Topic

Johnson & Johnson's vaccine

US probing two new blood clot cases after J&J's COVID-19 vaccine

US probing two new blood clot cases after J&J's COVID-19 vaccine

Published 27 Apr, 2021 08:27pm
  • One case was in a male and the other was in a female, both of whom were below 60 years, according to the agency, taking the total number of confirmed such cases to 17 out of 8 million shots given.
  • The new cases come after US health regulators on Friday recommended resumption of use of J&J's shot, ending a 10-day pause to investigate its link to extremely rare but potentially deadly blood clots.
South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses

South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses

Published 24 Apr, 2021 05:58pm
  • It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.
  • "The government has acquired COVID-19 vaccines large enough to vaccinate approximately 100 million people...(which) is double the entire population of South Korea," Health Minister Kwon Deok-cheol told a briefing.
J&J stands ready to roll out COVID-19 vaccine in Europe

J&J stands ready to roll out COVID-19 vaccine in Europe

Published 20 Apr, 2021 07:50pm
  • "It's an extremely rare event. We hope by making people aware as well as putting clear diagnostic and therapeutic guidance in place that we can restore the confidence in our vaccine," said J&J's Chief Scientific Officer Paul Stoffels.
  • J&J, during a call to discuss its first-quarter results, said it would fulfill its commitments to ship 200 million doses in Europe and 100 million in the United States.
EU regulator finds possible link between J&J COVID-19 vaccine and blood clots

EU regulator finds possible link between J&J COVID-19 vaccine and blood clots

Updated 20 Apr, 2021 07:32pm
  • The European Medicines Agency (EMA) said its safety committee concluded that a warning about unusual blood clots with low blood platelets should be added to the vaccine's labels.
  • The EMA found that all instances had occurred in adults under 60 years, mostly women, within three weeks of vaccination, adding that all available evidence, including eight reports of cases in the United States, were part of its assessment.
US panel to meet again next week to discuss pause on J&J's COVID-19 shot

US panel to meet again next week to discuss pause on J&J's COVID-19 shot

Updated 16 Apr, 2021 07:37pm
  • The US Centers for Disease Control and Prevention (CDC) advisory panel will meet on April 23, according to a notice posted on the regulator's website.
  • US health regulators recommended earlier this week that use of the J&J vaccine be paused after reports of six cases of rare brain blood clots in women.
Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks: WSJ

Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks: WSJ

Published 16 Apr, 2021 06:20pm
  • AstraZeneca, which had been buffeted by similar blood-clotting concerns for weeks, agreed, while Pfizer Inc and Moderna executive declined, saying their vaccines appeared safe, the report said.
  • The specific adverse event has not been reported by those who received the Pfizer and Moderna vaccines, the companies had said.=
Reaction after US recommends pause for J&J COVID-19 vaccine

Reaction after US recommends pause for J&J COVID-19 vaccine

Published 13 Apr, 2021 06:36pm
  • "Whilst a causal link between COVID-19 vaccination, platelet abnormalities and blood clots has not, so far, been confirmed, the index of suspicion is rising that these rare cases may be triggered by the adenovirus component of the AstraZeneca and J&J vaccines.
  • "Moreover, increasing awareness of the possibility of such side-effects means that they should be diagnosed more quickly and treated more successfully."
US calls for pause to J&J COVID-19 vaccine over rare blood clots

US calls for pause to J&J COVID-19 vaccine over rare blood clots

Published 13 Apr, 2021 05:48pm
  • The move comes a week after European regulators said they had found a possible link between AstraZeneca's COVID-19 vaccine and a rare blood clotting problem that had led to a small number of deaths.
  • Johnson & Johnson's (J&J) single dose vaccine - most COVID-19 shots are delivered over two doses - and AstraZeneca's low-cost vaccine are seen as vital tools in the fight against a pandemic that has claimed more than three million lives.
J&J begins COVID-19 vaccine supplies to EU, 50mn doses expected in Q2

J&J begins COVID-19 vaccine supplies to EU, 50mn doses expected in Q2

Published 12 Apr, 2021 07:31pm
  • The company had initially planned to start its deliveries at the beginning of April, but delayed the rollout due to production issues.
  • "Johnson & Johnson begins vaccine shipments to the EU today. Very good news," said Peter Liese, an EU lawmaker from the same party as German Chancellor Angela Merkel.
Spain to vaccinate 70-79 year olds with J&J's COVID-19 shot

Spain to vaccinate 70-79 year olds with J&J's COVID-19 shot

Published 12 Apr, 2021 06:33pm
  • Spain will take a first delivery of 300,000 doses of the single-shot vaccine on Wednesday morning, Carolina Darias told reporters at Gran Canaria airport after a visit to the Spanish Canary Islands.
  • Johnson & Johnson began delivering its vaccine to EU countries on Monday after some delays due to production issues, European Union officials and the company said.
EU reviews J&J COVID-19 vaccine for blood clots, expands AstraZeneca probe

EU reviews J&J COVID-19 vaccine for blood clots, expands AstraZeneca probe

Published 09 Apr, 2021 05:54pm
  • Four serious cases of rare blood clots with low platelets, one of which was fatal, have been reported after inoculation with J&J's vaccine from its Janssen unit, the European Medicines Agency said, adding five cases of capillary leak syndrome linked to AstraZeneca's vaccine were reported.
South African health regulator registers J&J's COVID-19 vaccine

South African health regulator registers J&J's COVID-19 vaccine

Published 01 Apr, 2021 08:05pm
  • J&J said in a statement that the South African Health Products Regulatory Authority (SAHPRA) had "granted registration with conditions" for its single-dose vaccine.
  • SAHPRA's spokesman confirmed that J&J's vaccine had been registered when called by Reuters. He said more details would follow in a statement.
Germany expects first delivery of J&J COVID-19 shot in mid-April

Germany expects first delivery of J&J COVID-19 shot in mid-April

Published 27 Mar, 2021 08:35pm
  • "It will only be a small delivery at first," Spahn told an online event, adding he expected a shipment of around 275,000 doses in the week of April 12.
  • J&J's shot, which was approved by European Union regulators on March 11, is the fourth to be endorsed for use in the EU after vaccines from Pfizer-BioNTech,, AstraZeneca-Oxford University and Moderna.
Thailand approves Johnson & Johnson's COVID-19 vaccine

Thailand approves Johnson & Johnson's COVID-19 vaccine

Published 25 Mar, 2021 07:06pm
  • Anutin Charnvirankul told reporters the Food and Drug Administration (FDA) had approved the vaccine, in addition to those of AstraZeneca and Sinovac Biotech, which have already been administered in the country.
  • J&J's vaccine is called COVID Vaccine Janssen after the J&J unit that developed it.
Vietnam seeks to diversify COVID-19 vaccine sources amid supply issues

Vietnam seeks to diversify COVID-19 vaccine sources amid supply issues

Published 24 Mar, 2021 07:14pm
  • "COVID-19 vaccine supplies for Vietnam have been impacted by the complicated developments of the coronavirus pandemic in the world," the government said in a statement.
  • Vietnam's vaccination campaign, which was launched on March 8, has relied solely on the batch of 117,600 doses of the AstraZeneca vaccine it received last month.
Catalent to ramp up J&J vaccine production at Italian plant

Catalent to ramp up J&J vaccine production at Italian plant

Published 17 Mar, 2021 08:21pm
  • The line, added as part of an expanded partnership with J&J, is expected to be operational in the fourth quarter, Catalent said.
  • The move will help address some of the concerns regarding J&J's ability to meet vaccine supply goals in Europe.
COVAX vaccine-sharing scheme to send out 'hundreds of millions' of J&J shots

COVAX vaccine-sharing scheme to send out 'hundreds of millions' of J&J shots

Published 17 Mar, 2021 05:40pm
  • COVAX, backed by WHO and the Global Alliance for Vaccines and Immunization, aims to secure 2 billion vaccine doses by the end of 2021.
  • In early March, it said the target was to deliver 237 million doses of AstraZeneca's shot to 142 countries by the end of May, and it also shipped its first Pfizer shots.
Germany's IDT to make J&J's COVID-19 shot using Takeda manufacturing capacity

Germany's IDT to make J&J's COVID-19 shot using Takeda manufacturing capacity

Updated 15 Mar, 2021 09:27pm
  • "I am grateful to our long-standing customer Takeda for its flexibility, which enables us to provide the world with much-needed COVID-19 vaccines," said IDT Biologika Chief Executive Juergen Betzing.
  • Dessau-based IDT is already producing AstraZeneca's COVID-19 vaccine, as well as developing its own shot against the coronavirus.
EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine

EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine

Published 11 Mar, 2021 06:48pm
  • The COVID-19 shot is the fourth to be endorsed for use in the EU after vaccines from Pfizer-BioNTech , AstraZeneca-Oxford University and Moderna, and is recommended for those over 18 years of age.
  • With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens.
US to procure additional 100mn doses of J&J COVID-19 vaccine

US to procure additional 100mn doses of J&J COVID-19 vaccine

Published 10 Mar, 2021 08:10pm
  • President Joe Biden will make the announcement at a meeting with the chief executives of J&J and Merck & Co later in the day, the official said. Merck has agreed to partner with J&J to produce its vaccine.
  • J&J's manufacturing has been slower than expected, and the company was not expected to be able to deliver any doses of its vaccine this week. It is expected to resume shipments later in March.
Moderna taps Baxter to support fill and finish of 60-90mn COVID-19 vaccine doses

Moderna taps Baxter to support fill and finish of 60-90mn COVID-19 vaccine doses

Updated 08 Mar, 2021 10:16pm
  • Moderna's two-shot vaccine is one of the three COVID-19 vaccines authorized for emergency use in the United States along with Pfizer/BioNTech and Johnson & Johnson's.
  • Under the pact with Baxter, the fill and finish of Moderna COVID-19 vaccine will take place at the sterile manufacturing facilities located in Bloomington, Indiana, the companies said.
Canada approves J&J's one-dose COVID-19 vaccine

Canada approves J&J's one-dose COVID-19 vaccine

Published 05 Mar, 2021 08:28pm
  • The official announcement will be made later on Friday, said the source, who requested anonymity given the sensitivity of the situation.
  • If the J&J vaccine has been approved, it could ease some logistical challenges. The vaccine is administered in a single dose and can be stored in normal fridges while the Pfizer-BioNTech and Moderna shots must be kept in freezers.
Loading...